BIO-FD&C Co.,Ltd. (KOSDAQ:251120)
South Korea
· Delayed Price · Currency is KRW 14,430
-60 (-0.41%)
At close: Apr 28, 2026
BIO-FD&C Market Cap
BIO-FD&C has a market cap or net worth of 125.48 billion as of April 28, 2026. Its market cap has increased by 11.00% in one year.
Market Cap
125.48B
Enterprise Value
73.07B
Revenue
19.18B
Ranking
n/a
PE Ratio
18.48
Stock Price
14,430.00
Market Cap Chart
Since February 21, 2022, BIO-FD&C's market cap has decreased from 193.04B to 125.48B, a decrease of -35.00%. That is a compound annual growth rate of -9.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 125.48B | -8.67% |
| Dec 30, 2025 | 137.39B | 14.33% |
| Dec 30, 2024 | 120.17B | -2.12% |
| Dec 28, 2023 | 122.78B | -16.94% |
| Dec 29, 2022 | 147.83B | -23.42% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NovMetaPharma | 121.99B |
| CORESTEMCHEMON | 141.73B |
| Cell Biotech | 111.01B |
| CHA Vaccine Research Institute | 103.70B |
| KoBioLabs | 103.50B |
| TegoScience | 103.20B |
| SunBio,Inc. | 98.77B |
| QuadMedicine | 164.54B |